Hainan Shuangcheng Pharmaceuticals (002693.SZ) Dividend: History, Dates & Yield - 2025
Tags:Dividend History
Hainan Shuangcheng Pharmaceuticals announced a annually dividend of ¥0.15 per ordinary share, payable on , with an ex-dividend date of 2015-03-10. Hainan Shuangcheng Pharmaceuticals typically pays dividends one times a year.
Find details on Hainan Shuangcheng Pharmaceuticals's dividend performance with a comprehensive history of past and upcoming payments.
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2015-03-10 | ¥0.15 | annually | |
| 2014-05-22 | ¥0.20 | annually | |
| 2013-05-16 | ¥0.35 | annually |
Dividend Increase
. In comparison, Haisco Pharmaceutical has seen an average growth rate of 51.40% over the past five years and Tianjin Lisheng Pharmaceutical's growth rate was 62.67%.
By comparing Hainan Shuangcheng Pharmaceuticals's dividend growth to other companies, investors can gain insight into how consistent its dividend strategy is and what that means for future payouts. However, dividend growth is just one factor to consider. Investors should also evaluate other metrics, such as earnings growth, payout ratio, and overall financial health, to get a full picture of Walmart's dividend sustainability and potential.
Dividend Yield
Hainan Shuangcheng Pharmaceuticals's current trailing twelve-month (TTM) dividend yield is nan%. Over the last 12 months, Hainan Shuangcheng Pharmaceuticals has maintained this yield, but how does it compare to similar stocks? For example, Haisco Pharmaceutical offers a yield of 1.61%, while Tianjin Lisheng Pharmaceutical provides a yield of 3.46%. Comparing similar stocks can help investors assess Hainan Shuangcheng Pharmaceuticals's yield and make more informed decisions.
| Company | Dividend Yield | Annual Dividend | Stock Price |
|---|---|---|---|
| Hainan Shuangcheng Pharmaceuticals (002693.SZ) | NaN% | ¥0.15 | ¥17 |
| Haisco Pharmaceutical (002653.SZ) | 1.61% | ¥0.345 | ¥29.54 |
| Tianjin Lisheng Pharmaceutical (002393.SZ) | 3.46% | ¥0.84 | ¥17.21 |
Dividend Yield Calculator
Interested in purchasing Hainan Shuangcheng Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield and see how Walmart's consistent payouts could contribute to your long-term investment goals. Understanding your potential returns can help you make an informed decision.
Payout Ratio
Hainan Shuangcheng Pharmaceuticals has a payout ratio of -0.10%. In comparison, Haisco Pharmaceutical has a payout ratio of 0.89%, while Chengdu Kanghong Pharmaceutical 's payout ratio is 0.29%.
It's important to note that the payout ratio is just one of many metrics investors use to assess a company's dividend sustainability and growth potential. It should be considered alongside other financial indicators such as earnings, cash flow, and debt levels to gain a complete picture of the company's financial health.
About Hainan Shuangcheng Pharmaceuticals
Frequently Asked Question
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Place an order: Use the brokerage's trading platform to place an order to buy Hainan Shuangcheng Pharmaceuticals stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.